Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by Justfishin73on Jun 06, 2017 1:41pm
179 Views
Post# 26330800

RE:RE:explanation

RE:RE:explanation
Justfishin73 wrote:
anmckenn wrote: can anyone offer up a viable explanation with what exactly is going on with these, is it that the legislation hype is over, pause before seasonal summer strength, lack of "big" news for the companies and sector or is there something im missing, maybe some bad PR, or Fed speak. What the word? im just trying to make sense of this.


All of the above, I see another 20% haircut over the next 8 weks


Well, that's 8% to the doubters
Bullboard Posts